Immunotherapy with histamine dihydrochloride for the prevention of relapse in acute myeloid leukemia

Reduced-Intensity Conditioning Hematopoietic Stem Cell Transplantation in Patients Over 60 Years: Hematologic Malignancy Outcomes Are Not Impaired in Advanced Age

(2010) John Koreth et al.   BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION

Exploiting cellular pathways to develop new treatment strategies for AML

(2010) Amir T. Fathi et al.   CANCER TREATMENT REVIEWS

Induction therapy in acute myeloid leukemia: intensifying and targeting the approach

(2010) Hugo F Fernandez et al.   CURRENT OPINION IN HEMATOLOGY

Myeloid-derived suppressor cell heterogeneity and subset definition

(2010) Elisa Peranzoni et al.   CURRENT OPINION IN IMMUNOLOGY

NK cell-mediated killing of AML blasts: role of histamine, monocytes and reactive oxygen metabolites

(2010) M. Brune et al.   EUROPEAN JOURNAL OF HAEMATOLOGY

Randomized Study of Intensified Anthracycline Doses for Induction and Recombinant Interleukin-2 for Maintenance in Patients With Acute Myeloid Leukemia Age 50 to 70 Years: Results of the ALFA-9801 Study

(2010) Cecile Pautas et al.   JOURNAL OF CLINICAL ONCOLOGY

Targeted treatment of acute myeloid leukemia in older adults: role of gemtuzumab ozogamicin

(2010) Hien Duong et al.   Clinical Interventions in Aging

Expected long-term survival of patients diagnosed with acute myeloblastic leukemia during 2006–2010

(2009) D. Pulte et al.   ANNALS OF ONCOLOGY

Peptide vaccines for patients with acute myeloid leukemia

(2009) Michael Schmitt et al.   Expert Review of Vaccines

Ncf1-Associated Reduced Oxidative Burst Promotes IL-33R+ T Cell-Mediated Adjuvant-Free Arthritis in Mice

(2009) K. Hagenow et al.   JOURNAL OF IMMUNOLOGY

Myeloid-Derived Suppressor Cells: Linking Inflammation and Cancer

(2009) S. Ostrand-Rosenberg et al.   JOURNAL OF IMMUNOLOGY

Anthracycline Dose Intensification in Acute Myeloid Leukemia

(2009) Hugo F. Fernandez et al.   NEW ENGLAND JOURNAL OF MEDICINE

Post-consolidation Immunotherapy with Histamine Dihydrochloride and Interleukin-2 in AML

(2009) A. I. Romero et al.   SCANDINAVIAN JOURNAL OF IMMUNOLOGY

The protective role of ROS in autoimmune disease

(2009) Malin Hultqvist et al.   TRENDS IN IMMUNOLOGY

High avidity myeloid leukemia-associated antigen-specific CD8+ T cells preferentially reside in the bone marrow

(2008) J. J. Melenhorst et al.   BLOOD

Internal tandem duplication of FLT3 (FLT3/ITD) induces increased ROS production, DNA damage, and misrepair: implications for poor prognosis in AML

(2008) A. Sallmyr et al.   BLOOD

How we diagnose and treat WHO-defined systemic mastocytosis in adults

(2008) A. Tefferi et al.   HAEMATOLOGICA

Molecular characterization of acute myeloid leukemia

(2008) K. Dohner et al.   HAEMATOLOGICA

Improvements in survival of adults diagnosed with acute myeloblastic leukemia in the early 21st century

(2008) D. Pulte et al.   HAEMATOLOGICA

Separation of graft-vs.-tumor effects from graft-vs.-host disease in allogeneic hematopoietic cell transplantation

(2008) Andrew R. Rezvani et al.   JOURNAL OF AUTOIMMUNITY

Low-Dose Interleukin-2 Immunotherapy Does Not Improve Outcome of Patients Age 60 Years and Older With Acute Myeloid Leukemia in First Complete Remission: Cancer and Leukemia Group B Study 9720

(2008) Maria R. Baer et al.   JOURNAL OF CLINICAL ONCOLOGY